Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Michael Geffner

Chief Medical Officer at Immunovant, Inc. (IMVT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $70K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 24SEC IMVTImmunovant, Inc. Sell 2,595217,958 held (−1%) $19.03 $49K +40.5%
Oct 10SEC IMVTImmunovant, Inc. Sell 1,272220,553 held (−1%) $16.30 $21K +64.0%